Skip to Content
Jump to the top of the page

Equity Research

Capital ideas from the industry’s brightest minds.

Our award-winning equity research analysts deliver superior investment ideas and value-added perspective for over 700 companies, across seven growth-oriented sectors: consumer; energy and power technologies; financial services and technology; industrials; global services; healthcare; and technology, media, and communications. William Blair’s research universe is diversified across multiple industry verticals and a wide range of market capitalization, with an emphasis on quality business models in their emerging growth phase of development.

  • 700+

    companies under
    research coverage

  • 70%+

    of coverage dedicated to small- and mid-cap growth companies

  • 110

    analysts and research
    professionals

As of March 31, 2026

William Blair analysts seek to cover only companies that have above-average growth prospects and above-average quality. They use multiple factors to identify high-quality companies with attractive growth prospects, including the company’s product line, level of service, and management experience.

Our clients include:

  • Mutual Funds
  • Investment Advisory Firms
  • Banks
  • Pension Funds
  • Insurance Companies
  • Money Managers Across North America, Europe, and Asia

Through exhaustive fundamental research and unique insight derived from independent thinking, our award-winning analysts work tirelessly to identify companies that can deliver superior investment returns for our clients.

Recent News

  • Wise Group, plc: Initiation of Research Coverage

    William Blair initiated research coverage of Wise Group, plc (WSE $14.50), a technology company focused on improving the cross-border payments market. Wise commenced its listing on the Nasdaq at the start of trading on May 11 and maintains a secondary listing on the London Stock Exchange.

    Read more
  • Arxis, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Arxis, Inc. (ARXS $35.03), a designer and manufacturer of proprietary, mission-critical electronic and mechanical components serving the aerospace, defense, and industrial technology markets.

    Read more
  • Madison Air Solutions Corporation: Initiation of Research Coverage

    William Blair initiated research coverage of Madison Air Solutions Corporation (MAIR $42.20), which manufactures and sells a variety of solutions focused on air quality, air safety, and energy efficiency.

    Read more
  • William Blair Thinking Podcast

    Navigating the current market environment demands the right informational resource. That is why we launched the William Blair Thinking Podcast, which aims to provide in-depth expertise on today's financial and economic landscape.

    What's different about this platform?
    It's our most timely and best ideas—the ethos, if you will, of our firm's intellectual capital. All in 20 minutes.

    Our latest podcasts
  • William Blair Shines in 2024 Coalition Greenwich Study with 12 No. 1 Rankings

    William Blair, the premier global partnership with expertise in investment banking, investment management, and private wealth management, is thrilled to announce its performance in the annual Coalition Greenwich Voice of the Client – 2024 North American Equity Investors Study.

    Learn more

Macro Highlights from Our 2025 Growth Stock Conference

In a special economics conference report, William Blair’s Richard de Chazal highlights commentary from the event, which featured more than 250 public and private companies.

Read more

Featured Insights

  • From Code to Clinic: How AI Is (and Isn’t) Rewriting the Life of a Drug

    In this episode of William Blair Thinking Presents, Matt Larew, partner and equity research analyst covering life science tools and diagnostics, explains where AI is accelerating early discovery, why wet‑lab validation still matters, and what real progress looks like as adoption moves from hype to practice.

    Listen to the podcast
  • Tracking the $8 Billion Alzheimer’s Disease Diagnostics Market

    As new Alzheimer’s therapies emerge, diagnostics are becoming an essential infrastructure for screening, treatment decisions, and ongoing monitoring.

    Read more
  • Economics Weekly: Curb Your Enthusiasm (for a Housing Recovery)

    In this Economics Weekly, Richard de Chazal examines the U.S. housing market and discusses its opportunities and challenges in the year ahead.

    Read more

Corporate Access

Our non-deal roadshows, conferences, and investor field trips facilitate the exchange of ideas and build relationships between senior corporate management and key decision makers with leading institutional investors.

Learn more
People in a conference room

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures